EBEWE Pharma
| Sandoz Biopharmaceuticals and Oncology Injectables, EBEWE Pharma Ges.mbH Nfg.KG
|
|
|---|---|
 |
|
| legal form | GmbH |
| founding | 1934 |
| Seat | Unterach am Attersee , Austria |
| management | Gunther Kronnerwetter, Ulrike Zschuppe |
| Number of employees | 550 |
| sales | EUR 222 million |
| Branch | pharmacy |
| Website | https://www.sandoz.at/ueber-uns/wer-wir-sind |
EBEWE Pharma is a pharmaceutical company founded by Emil Bertalanffy in Vienna in 1934 and based in Unterach am Attersee ( Upper Austria ).
history
The company was founded in Vienna in 1934 as Emil Bertalanffy Werke , and the company headquarters, including the research facility and production facility, moved to Unterach in the Salzkammergut in 1945 . In the period from 1956 to 2001, EBEWE was part of the German company BASF and, when Abbott Laboratories took over the pharmaceutical division of BASF in early 2001, was part of the US Abbott group for a short time .
A group of investors led by Friedrich Hillebrand bought the company from the Abbott Group in a management buyout . In May 2009, Sandoz acquired the generic drug business from EBEWE for EUR 925 million.
Products
EBEWE manufactures more than 25 chemotherapy and supplement products, including the following drugs :
- Alexan ( cytarabine )
- Immunoprine ( azathioprine )
- Calcium folinate EBEWE
Individual evidence
- ↑ About and / The management accessed on March 20, 2019
- ↑ Österreichische Apothekerzeitung (edition 14/2002)
- ↑ Sandoz acquires EBEWE Pharma's specialty generic drug business, improving access to injectable cancer drugs for patients worldwide , Novartis press release of May 20, 2009